Pasithea Therapeutics (KTTA) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $0.41, +0.24% vs the prior close of $0.41.
- Volume 20.60K shares, 0.1x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
KTTA ends flat (+0.2%) to $0.41. Closed at $0.41, +0.24% vs the prior close of $0.41. Day range $0.40–$0.44, opened at $0.41.
KTTA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — KTTA ends flat (+0.2%) to $0.41
- Closed at $0.41, +0.24% vs the prior close of $0.41. Day range $0.40–$0.44, opened at $0.41.
- Volume was 20.60K shares, 0.1x its 50-day average of 179.45K — lighter than usual.
- Price is -18.5% vs its 50-day average ($0.50) and -38.4% vs its 200-day average ($0.67).
- 52-week range $0.28–$2.06; today's close sits at 7% of that range, 80.1% below the 52-week high.
Oct 14, 2026 — KTTA slides 3.5% to $0.41, a 6-month low on 3.6x normal volume
- Closed at $0.41, -3.54% vs the prior close of $0.42. Day range $0.38–$0.44, opened at $0.44.
- Volume was 616.50K shares, 3.6x its 50-day average of 169.63K — unusually heavy trading.
- Price is -18.8% vs its 50-day average ($0.50) and -38.9% vs its 200-day average ($0.67).
- 52-week range $0.28–$2.06; today's close sits at 7% of that range, 80.1% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — KTTA slides 5.4% to $0.42, a 6-month low
- Closed at $0.42, -5.36% vs the prior close of $0.45. Day range $0.41–$0.45, opened at $0.45.
- Volume was 60.10K shares, 0.3x its 50-day average of 175.27K — lighter than usual.
- Price is -16.0% vs its 50-day average ($0.50) and -37.0% vs its 200-day average ($0.67).
- 52-week range $0.28–$2.06; today's close sits at 8% of that range, 79.4% below the 52-week high.
Oct 12, 2026 — KTTA slides 4.3% to $0.45
- Closed at $0.45, -4.27% vs the prior close of $0.47. Day range $0.45–$0.47, opened at $0.47.
- Volume was 80.70K shares, 0.5x its 50-day average of 178.71K — lighter than usual.
- Price is -11.3% vs its 50-day average ($0.51) and -33.8% vs its 200-day average ($0.68).
- 52-week range $0.28–$2.06; today's close sits at 9% of that range, 78.3% below the 52-week high.
Oct 9, 2026 — KTTA jumps 6.1% to $0.47
- Closed at $0.47, +6.12% vs the prior close of $0.44. Day range $0.45–$0.47, opened at $0.45.
- Volume was 60.60K shares, 0.3x its 50-day average of 188.94K — lighter than usual.
- Price is -7.4% vs its 50-day average ($0.51) and -31.2% vs its 200-day average ($0.68).
- 52-week range $0.28–$2.06; today's close sits at 11% of that range, 77.3% below the 52-week high.
Oct 8, 2026 — KTTA dips 0.5% to $0.44, a 6-month low, 6 down days in a row
- Closed at $0.44, -0.45% vs the prior close of $0.44. Day range $0.44–$0.47, opened at $0.45.
- Volume was 56.20K shares, 0.3x its 50-day average of 195.95K — lighter than usual.
- Price is -12.7% vs its 50-day average ($0.50) and -35.5% vs its 200-day average ($0.68).
- 52-week range $0.28–$2.06; today's close sits at 9% of that range, 78.6% below the 52-week high.
- That makes 6 straight losses.
Oct 7, 2026 — KTTA dips 0.9% to $0.44, a 6-month low, 5 down days in a row
- Closed at $0.44, -0.89% vs the prior close of $0.45. Day range $0.44–$0.47, opened at $0.45.
- Volume was 132.50K shares, 0.7x its 50-day average of 197.95K.
- Price is -12.3% vs its 50-day average ($0.51) and -35.6% vs its 200-day average ($0.69).
- 52-week range $0.28–$2.06; today's close sits at 9% of that range, 78.5% below the 52-week high.
- That makes 5 straight losses.
Oct 6, 2026 — KTTA dips 1.8% to $0.45, a 1-month low, 4 down days in a row
- Closed at $0.45, -1.76% vs the prior close of $0.46. Day range $0.44–$0.47, opened at $0.47.
- Volume was 64.10K shares, 0.3x its 50-day average of 203.81K — lighter than usual.
- Price is -11.5% vs its 50-day average ($0.51) and -35.3% vs its 200-day average ($0.69).
- 52-week range $0.28–$2.06; today's close sits at 9% of that range, 78.3% below the 52-week high.
- That makes 4 straight losses.
Oct 5, 2026 — KTTA slides 4.4% to $0.46, a 1-month low, 3 down days in a row
- Closed at $0.46, -4.41% vs the prior close of $0.48. Day range $0.46–$0.51, opened at $0.49.
- Volume was 84.60K shares, 0.4x its 50-day average of 208.62K — lighter than usual.
- Price is -10.0% vs its 50-day average ($0.51) and -34.5% vs its 200-day average ($0.69).
- 52-week range $0.28–$2.06; today's close sits at 10% of that range, 77.9% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — KTTA dips 2.7% to $0.48, a 1-month low
- Closed at $0.48, -2.66% vs the prior close of $0.49. Day range $0.47–$0.51, opened at $0.47.
- Volume was 59.80K shares, 0.3x its 50-day average of 213.65K — lighter than usual.
- Price is -5.8% vs its 50-day average ($0.51) and -31.8% vs its 200-day average ($0.70).
- 52-week range $0.28–$2.06; today's close sits at 11% of that range, 76.9% below the 52-week high.
KTTA latest news & SEC filings
Every SEC filing by or about KTTA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 16, 2026 · Form 25-NSE — Notice that a security is being removed from exchange listing
Notice that a security is being removed from exchange listing
Sep 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Aug 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$5.27M (prior year -$3.72M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.16 (prior year -$0.66) (loss narrowed vs Jun 30, 2025)
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 7, 2026 · Form ARS — Annual report to shareholders
Annual report to shareholders
Aug 7, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Jul 31, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 29, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Jul 1, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 23, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Coastlands Capital Lp bought 100,000 shares at $0.53 (≈$53.00K) on Jun 17, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Things to know before you trade KTTA
- How much it moves: over the last 20 sessions the average daily move was 2.36% (largest 6.1%).
- Liquidity: about 131.50K shares (≈$53.91K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.41 vs a range of $0.28–$2.06 (7% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 0 sales; latest: Capital Lp Coastlands bought 100,000 shares on Jun 17, 2026.
- Latest filings: 8-K Sep 16, 2026; 8-K Sep 9, 2026; 8-K Aug 21, 2026.
- Share count: 33.41M shares outstanding (Aug 12, 2026), +348.9% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
KTTA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 0.41 | 0.44 | 0.40 | 0.41 | 20.60K |
| Oct 14, 2026 | 0.44 | 0.44 | 0.38 | 0.41 | 616.50K |
| Oct 13, 2026 | 0.45 | 0.45 | 0.41 | 0.42 | 60.10K |
| Oct 12, 2026 | 0.47 | 0.47 | 0.45 | 0.45 | 80.70K |
| Oct 9, 2026 | 0.45 | 0.47 | 0.45 | 0.47 | 60.60K |
| Oct 8, 2026 | 0.45 | 0.47 | 0.44 | 0.44 | 56.20K |
| Oct 7, 2026 | 0.45 | 0.47 | 0.44 | 0.44 | 132.50K |
| Oct 6, 2026 | 0.47 | 0.47 | 0.44 | 0.45 | 64.10K |
| Oct 5, 2026 | 0.49 | 0.51 | 0.46 | 0.46 | 84.60K |
| Oct 2, 2026 | 0.47 | 0.51 | 0.47 | 0.48 | 59.80K |
| Oct 1, 2026 | 0.49 | 0.50 | 0.48 | 0.49 | 12.00K |
| Sep 30, 2026 | 0.49 | 0.51 | 0.48 | 0.49 | 60.00K |
| Sep 29, 2026 | 0.47 | 0.50 | 0.46 | 0.49 | 141.50K |
| Sep 28, 2026 | 0.49 | 0.50 | 0.45 | 0.48 | 151.20K |
| Sep 25, 2026 | 0.50 | 0.51 | 0.49 | 0.50 | 94.80K |
| Sep 24, 2026 | 0.50 | 0.53 | 0.50 | 0.51 | 105.10K |
| Sep 23, 2026 | 0.51 | 0.52 | 0.50 | 0.51 | 113.90K |
| Sep 22, 2026 | 0.53 | 0.53 | 0.50 | 0.51 | 165.00K |
| Sep 21, 2026 | 0.51 | 0.52 | 0.50 | 0.51 | 67.60K |
| Sep 18, 2026 | 0.52 | 0.55 | 0.49 | 0.52 | 483.20K |
About Pasithea Therapeutics
Pasithea Therapeutics (KTTA) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in MIAMI BEACH, FL. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1841330.
KTTA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Simon Dumesnil | Director | May 5, 2026 |
| Emer Leahy | Director | May 5, 2026 |
| Tiago Marques | Chief Executive Officer | May 5, 2026 |
| Alfred J Novak | Director | May 5, 2026 |
| Lawrence Steinman | Director | May 5, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Kartik Krishnan | Chief Medical Officer | May 5, 2026 |
| Tiago Marques | Chief Executive Officer | May 5, 2026 |
| Daniel H Schneiderman | Chief Financial Officer | May 5, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 17, 2026 | Capital Lp Coastlands | Buy | 100,000 | $0.53 |
| Nov 28, 2025 | Lawrence Steinman | Buy | 133,333 | $0.75 |
| Nov 28, 2025 | Simon Dumesnil | Buy | 33,333 | $0.75 |
| Nov 28, 2025 | Tiago Marques | Buy | 33,333 | $0.75 |
KTTA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-20.43M | -2.91 | $-15.21M |
| Dec 31, 2024 | — | $-13.90M | -12.69 | $-13.92M |
| Dec 31, 2023 | — | $-15.96M | -0.42 | — |
| Dec 31, 2022 | $486.56K | $-13.94M | -1.76 | $-14.56M |
| Dec 31, 2021 | $15.06K | $-2.17M | -0.21 | $-3.17M |
Latest balance sheet: total assets $51.71M, total liabilities $1.87M, cash $45.66M (as of Jun 30, 2026).
KTTA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on KTTA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.